Literature DB >> 26241380

Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan.

Curtis Dolezal1, Timothy Frasca1, Rebecca Giguere1, Mobolaji Ibitoye2, Ross D Cranston3, Irma Febo4, Kenneth H Mayer5, Ian McGowan6, Alex Carballo-Diéguez1.   

Abstract

This study examines awareness of and experiences with post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) among 228 men recruited in Boston, Pittsburgh, and San Juan between 12/2010 and 6/2012. All of them reported having condomless anal sex with a man in the prior year. Overall, 41% had heard of PEP, ranging from 16% in San Juan to 64% in Boston. Only 21% had heard of PrEP, ranging from 8% in San Juan to 36% in Boston. Three had used PEP, and none had used PrEP. After the methods were described to participants, interest in both was high, with intentions to use PEP and PrEP respectively at 9.1 and 7.7 (10-point scale). Increased public education is needed to raise awareness of these HIV prevention methods, especially among MSM who acknowledge potential risk behavior. It also seems likely that many such men would use these methods once they become aware of them.

Entities:  

Mesh:

Year:  2015        PMID: 26241380      PMCID: PMC4610145          DOI: 10.1521/aeap.2015.27.4.289

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  20 in total

1.  Lack of awareness of HIV post-exposure prophylaxis among HIV-infected and uninfected men attending an inner London clinic.

Authors:  Shamela de Silva; Robert F Miller; John Walsh
Journal:  Int J STD AIDS       Date:  2006-09       Impact factor: 1.359

2.  Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

Authors:  Dawn K Smith; Lisa A Grohskopf; Roberta J Black; Judith D Auerbach; Fulvia Veronese; Kimberly A Struble; Laura Cheever; Michael Johnson; Lynn A Paxton; Ida M Onorato; Alan E Greenberg
Journal:  MMWR Recomm Rep       Date:  2005-01-21

3.  Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

Authors:  J O Kahn; J N Martin; M E Roland; J D Bamberger; M Chesney; D Chambers; K Franses; T J Coates; M H Katz
Journal:  J Infect Dis       Date:  2001-02-01       Impact factor: 5.226

4.  Awareness of non-occupational HIV postexposure prophylaxis among French people living with HIV: the need for better targeting.

Authors:  Dominique Rey; Anne-Déborah Bouhnik; Patrick Peretti-Watel; Yolande Obadia; Bruno Spire
Journal:  AIDS       Date:  2007-01       Impact factor: 4.177

5.  Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.

Authors:  Albert Y Liu; Pravina V Kittredge; Eric Vittinghoff; H Fisher Raymond; Katherine Ahrens; Tim Matheson; Jennifer Hecht; Jeffrey D Klausner; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

6.  Awareness of HIV post-exposure prophylaxis after sexual exposure and emergency hormonal contraception in HIV-positive women.

Authors:  M Samuel; C Taylor; M Brady; C McDonald; M Poulton; M Tenant-Flowers
Journal:  Int J STD AIDS       Date:  2008-01       Impact factor: 1.359

7.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

8.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

9.  Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.

Authors:  Mauro Schechter; Regina F do Lago; Aaron B Mendelsohn; Ronaldo I Moreira; Lawrence H Moulton; Lee H Harrison
Journal:  J Acquir Immune Defic Syndr       Date:  2004-04-15       Impact factor: 3.731

10.  Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials.

Authors:  Junjun Jiang; Xiaoyi Yang; Li Ye; Bo Zhou; Chuanyi Ning; Jiegang Huang; Bingyu Liang; Xiaoni Zhong; Ailong Huang; Renchuan Tao; Cunwei Cao; Hui Chen; Hao Liang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  31 in total

1.  PrEP Knowledge and Attitudes Among Adults Attending Public Health Clinics in Southern Arizona.

Authors:  Tanwe C Shende; Julia M Fisher; Carlos M Perez-Velez; Alyssa A Guido; Kristi M Sprowl; Taylor M Drake; Maria L Adelus; Edward J Bedrick; Lori E Fantry
Journal:  J Community Health       Date:  2020-04

2.  Potential Healthcare Insurance and Provider Barriers to Pre-Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men.

Authors:  Sarah J Marks; Roland C Merchant; Melissa A Clark; Tao Liu; Joshua G Rosenberger; Jose Bauermeister; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2017-11       Impact factor: 5.078

3.  Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city.

Authors:  Matthew Garnett; Yael Hirsch-Moverman; Julie Franks; Eleanor Hayes-Larson; Wafaa M El-Sadr; Sharon Mannheimer
Journal:  AIDS Care       Date:  2017-08-09

Review 4.  As through a glass, darkly: the future of sexually transmissible infections among gay, bisexual and other men who have sex with men.

Authors:  Mark Richard Stenger; Stefan Baral; Shauna Stahlman; Dan Wohlfeiler; Jerusha E Barton; Thomas Peterman
Journal:  Sex Health       Date:  2017-02       Impact factor: 2.706

5.  Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada.

Authors:  S Y Lin; N J Lachowsky; M Hull; A Rich; Z Cui; P Sereda; J Jollimore; K Stephenson; M Thumath; Jsg Montaner; E A Roth; R S Hogg; D M Moore
Journal:  HIV Med       Date:  2016-08-01       Impact factor: 3.180

6.  Applying the Information-Motivation-Behavioral Skills Model to Understand PrEP Intentions and Use Among Men Who Have Sex with Men.

Authors:  Jennifer L Walsh
Journal:  AIDS Behav       Date:  2019-07

7.  The Pre-exposure Prophylaxis (PrEP) Continuum of Care and Correlates to Initiation Among HIV-Negative Men Recruited at Miami Gay Pride 2018.

Authors:  Angel B Algarin; Cho Hee Shrader; Chintan Bhatt; Benjamin T Hackworth; Robert L Cook; Gladys E Ibañez
Journal:  J Urban Health       Date:  2019-12       Impact factor: 3.671

8.  Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men.

Authors:  Lisa A Eaton; Seth C Kalichman; Devon Price; Stephanie Finneran; Aerielle Allen; Jessica Maksut
Journal:  AIDS Behav       Date:  2017-05

9.  MALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing Enema.

Authors:  Herana Kamal Seneviratne; Craig W Hendrix; Edward J Fuchs; Namandjé N Bumpus
Journal:  J Pharmacol Exp Ther       Date:  2018-07-23       Impact factor: 4.030

10.  The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.

Authors:  Suzan M Walters; Bethany Coston; Alan Neaigus; Alexis V Rivera; Lila Starbuck; Valentina Ramirez; Kathleen H Reilly; Sarah L Braunstein
Journal:  Int J Drug Policy       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.